CAS: 536731-65-4
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | 2-(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)-N-[4-(3-methoxyphenyl)-1,3-thiazol-2-yl]acetamide REF: IN-DA01NXUSCAS: 536731-65-4 | 98% | A consultar | Mar 10 Dic 24 |
 | GSK-3β inhibitor 11 REF: TM-T61809CAS: 536731-65-4 | 97.33% | 74,00 €~1.171,00 € | Vie 24 Ene 25 |
![2-(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)-N-[4-(3-methoxyphenyl)-1,3-thiazol-2-yl]acetamide](https://static.cymitquimica.com/products/IN/thumb/DA01NXUS.jpg)
2-(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)-N-[4-(3-methoxyphenyl)-1,3-thiazol-2-yl]acetamide
CAS:536731-65-4
Fórmula:
C20H15N3O4S
Pureza:
98%
Peso molecular:
393.4158
Ref: IN-DA01NXUS
| 5mg | 183,00 € | ||
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 10 de Diciembre de 2024
GSK-3β inhibitor 11
CAS:536731-65-4
GSK-3β inhibitor 11 (compound 21) is a potent inhibitor of glycogen synthase kinase-3β (GSK-3β) with …
Fórmula:
C20H15N3O4S
Pureza:
97.33%
Forma y color:
Solid
Peso molecular:
393.42
Ref: TM-T61809
| 5mg | 74,00 € | ||
| 10mg | 105,00 € | ||
| 25mg | 212,00 € | ||
| 50mg | 343,00 € | ||
| 100mg | 549,00 € | ||
| 500mg | 1.171,00 € |
Entrega estimada en Estados Unidos, el Viernes 24 de Enero de 2025
